Skip to main content
. 2015 Jan;27(78):43–54.

Table4.

Distribution of oral findings regarding to co-infection with HBV, HCV and HTLV1

Oral Findings HCV Positive HCV
Negative
P value
(HCV)
HBV Positive HBV Negative P value
(HBV)
HTLV1 Positive HTLV1 Negative P value
(HTLV)
No (%) No (%) N0 (%) No (%) No (%) No (%)
Tooth Decays 25(43.1) 21(40.4) 0.77 6(54.5) 40(40.4) 0.36 6(75) 40(39.2) 0.04
Severe Periodontitis 20(34.5) 10(19.2) 0.73 4(36.4) 26(26.3) 0.47 2(25) 28(27.5) 0.88
Pseudomembranous Candidiasis 21(36.2) 5(9.6) 0.01 3(27.3) 23(23.2) 0.76 1(12.5) 25(24.5) 0.44
Hairy Tongue 16(27.6) 10(19.2) 0.30 3(27.3) 23(23.2) 0.76 1(12.5) 25(24.5) 0.44
Xerostomia 11(19) 11(21.2) 0.77 1(9.1) 21(21.2) 0.34 4(50) 18(17.6) 0.02
HSV Infection 11(19) 11(21.2) 0.77 1(9.1) 21(21.2) 0.34 3(37.5) 19(18.6) 0.19
Erythematous Candidiasis 14(24.1) 7(13.5) 0.15 2(18.2) 19(19.2) 0.93 1(12.5) 20(19.6) 0.62
Hyperpigmentation 6(10.3) 14(26.9) 0.02 1(9.1) 19(19.2) 0.41 0(0) 20(19.6) 0.16
Aphthous Ulcer 7(12.1) 5(9.6) 0.68 1(9.1) 11(11.1) 0.83 1(12.5) 11(10.8) 0.88
Angular Cheilitis 7(12.1) 3(5.8) 0.25 1(9.1) 9(9.1) 1 0(0) 10(9.8) 0.35
Non-specific Ulcers 9(15.5) 0(0) 0.003 0(0) 9(9.1) 0.29 0(0) 9(8.8) 0.38
Verruca Vulgaris 2(3.4) 5(9.6) 0.18 0(0) 7(7.1) 0.36 1(12.5) 6(5.9) 0.46
Fissured Tongue 3(5.2) 3(5.8) 0.89 0(0) 6(6.1) 0.40 0(0) 6(5.9) 0.48
Keratosis 4(6.9) 1(1.9) 0.21 1(9.1) 4(4) 0.44 0(0) 5(4.9) 0.52
Salivary Gland Disease 3(5.2) 2(3.8) 0.73 0(0) 5(5.1) 0.44 0(0) 5(4.9) 0.52
Lichenoid reactions 0(0) 5(9.6) 0.01 0(0) 5(5.1) 0.44 0(0) 5(4.9) 0.52
Trigeminal Neuralgia 1(1.7) 4(7.7) 0.13 0(0) 5(5.1) 0.44 0(0) 5(4.9) 0.52
Necrotizing Ulcerative Gingivitis 2(3.4) 0(0) 0.17 0(0) 2(2) 0.63 0(0) 2(2) 0.68
Necrotizing Ulcerative Periodontitis 3(5.2) 0(0) 0.09 0(0) 3(3) 0.55 1(12.5) 2(2) 0.07
Trombocytopenic Purpura 0(0) 1(1.9) 0.28 0(0) 1(1) 0.73 0(0) 1(1) 0.77